{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:21:14Z","timestamp":1794406874951,"version":"4.9.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jaad.2019.08.001","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T11:17:09Z","timestamp":1565176629000},"page":"425-429","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":87,"title":["Prevalence estimates for pyoderma gangrenosum in the United States: An age- and sex-adjusted population analysis"],"prefix":"10.1016","volume":"83","author":[{"given":"Amy","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Balgobind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Strunk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allireza","family":"Alloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaad.2019.08.001_bib1","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jamadermatol.2017.5978","article-title":"The association of age with clinical presentation and comorbidities of pyoderma gangrenosum","volume":"154","author":"Ashchyan","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.001_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaad.2015.06.054","article-title":"Postoperative pyoderma gangrenosum (PG): the Mayo Clinic experience of 20 years from 1994 through 2014","volume":"73","author":"Tolkachjov","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2019.08.001_bib3","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.mayocp.2016.05.001","article-title":"Postoperative pyoderma gangrenosum: a clinical review of published cases","volume":"91","author":"Tolkachjov","year":"2016","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.001_bib4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1001\/jamadermatol.2017.5980","article-title":"Diagnostic criteria of ulcerative pyoderma gangrenosum: a Delphi consensus of international experts","volume":"154","author":"Maverakis","year":"2018","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.001_bib5","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.jaad.2015.06.021","article-title":"Pathophysiology of pyoderma gangrenosum (PG): an updated review","volume":"73","author":"Braswell","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.001_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1046\/j.1523-1747.1998.00311.x","article-title":"Aberrant neutrophil trafficking and metabolic oscillations in severe pyoderma gangrenosum","volume":"111","author":"Adachi","year":"1998","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.001_bib7","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/labinvest.3780064","article-title":"Interleukin-8 overexpression is present in pyoderma gangrenosum ulcers and leads to ulcer formation in human skin xenografts","volume":"80","author":"Oka","year":"2000","journal-title":"Lab Invest"},{"issue":"7","key":"10.1016\/j.jaad.2019.08.001_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0025-6196(11)63565-9","article-title":"A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome","volume":"72","author":"Lindor","year":"1997","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.001_bib9","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1086\/302866","article-title":"Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome maps to chromosome 15q","volume":"66","author":"Yeon","year":"2000","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jaad.2019.08.001_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/CCID.S61202","article-title":"Pyoderma gangrenosum: challenges and solutions","volume":"8","author":"Gameiro","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"12","key":"10.1016\/j.jaad.2019.08.001_bib11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.12968\/jowc.2009.18.12.45610","article-title":"Pyoderma gangrenosum: from misdiagnosis to recognition, a personal perspective","volume":"18","author":"Hemp","year":"2009","journal-title":"J Wound Care"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.001_bib12","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/j.1365-2133.2011.10565.x","article-title":"Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients","volume":"165","author":"Binus","year":"2011","journal-title":"Br J Dermatol"},{"issue":"18","key":"10.1016\/j.jaad.2019.08.001_bib13","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJMoa013383","article-title":"Skin ulcers misdiagnosed as pyoderma gangrenosum","volume":"347","author":"Weenig","year":"2002","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.001_bib14","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/bjd.16446","article-title":"The validity of the diagnostic code for pyoderma gangrenosum in an electronic database","volume":"179","author":"Lockwood","year":"2018","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2019.08.001_bib15","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1038\/jid.2012.130","article-title":"Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.001_bib16","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/iwj.12939","article-title":"Epidemiology of pyoderma gangrenosum: results from an Italian prospective multicentre study","volume":"15","author":"Monari","year":"2018","journal-title":"Int Wound J"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.001_bib17","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ad.2011.04.010","article-title":"Pyoderma gangrenosum: a report of 15 cases and review of the literature","volume":"103","author":"Su\u00e1rez-P\u00e9rez","year":"2012","journal-title":"Actas Dermosifiliogr"},{"issue":"5","key":"10.1016\/j.jaad.2019.08.001_bib18","first-page":"361","article-title":"Pyoderma gangrenosum among patients with inflammatory bowel disease: a descriptive cohort study","volume":"18","author":"Weizman","year":"2014","journal-title":"J Cutan Med Surg"},{"issue":"8","key":"10.1016\/j.jaad.2019.08.001_bib19","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1111\/j.1572-0241.2003.07581.x","article-title":"Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease","volume":"98","author":"Regueiro","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaad.2019.08.001_bib20","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1572-0241.2001.03756.x","article-title":"The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study","volume":"96","author":"Bernstein","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.001_bib21","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1046\/j.1365-2133.1997.20022083.x","article-title":"Pyoderma gangrenosum: a report of 44 cases with follow-up","volume":"137","author":"von den Driesch","year":"1997","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.001_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/00005792-200001000-00004","article-title":"Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions","volume":"79","author":"Bennett","year":"2000","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"10.1016\/j.jaad.2019.08.001_bib23","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1610-0387.2011.07734.x","article-title":"Investigation of new co-factors in 49 patients with pyoderma gangrenosum","volume":"10","author":"Al Ghazal","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2019.08.001_bib24","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1750-1172-8-136","article-title":"Associated factors and comorbidities in patients with pyoderma gangrenosum in Germany: a retrospective multicentric analysis in 259 patients","volume":"8","author":"Al Ghazal","year":"2013","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.jaad.2019.08.001_bib25","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cgh.2016.10.039","article-title":"Incidence and prevalence of Crohn's disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010","volume":"15","author":"Shivashankar","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.001_bib26","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1136\/gut.46.3.336","article-title":"Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival","volume":"46","author":"Loftus","year":"2000","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.jaad.2019.08.001_bib27","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1002\/cncr.22233","article-title":"Acute myeloid leukemia: epidemiology and etiology","volume":"107","author":"Deschler","year":"2006","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.jaad.2019.08.001_bib28","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/bjc.2011.450","article-title":"Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network","volume":"105","author":"Smith","year":"2011","journal-title":"Br J Cancer"},{"issue":"21","key":"10.1016\/j.jaad.2019.08.001_bib29","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/jnci\/djn349","article-title":"Characteristics of US patients with myelodysplastic syndromes: results of six cross-sectional physician surveys","volume":"100","author":"Sekeres","year":"2008","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.001_bib30","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cellimm.2015.02.002","article-title":"Sex, the aging immune system, and chronic disease","volume":"294","author":"Gubbels Bupp","year":"2015","journal-title":"Cell Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.001_bib31","doi-asserted-by":"crossref","first-page":"600","DOI":"10.2353\/ajpath.2008.071008","article-title":"Sex differences in autoimmune disease from a pathological perspective","volume":"173","author":"Fairweather","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jaad.2019.08.001_bib32","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3389\/fimmu.2015.00635","article-title":"The immune system is a natural target for estrogen action: opposing effects of estrogen in two prototypical autoimmune diseases","volume":"6","author":"Khan","year":"2016","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.001_bib33","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1600-0897.2004.00177.x","article-title":"Gender difference in the non-specific and specific immune response in humans","volume":"52","author":"Bouman","year":"2004","journal-title":"Am J Reprod Immunol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.001_bib34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/archderm.142.3.371","article-title":"Sex hormones and the genesis of autoimmunity","volume":"142","author":"Ackerman","year":"2006","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2019.08.001_bib35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0014-5793(98)00039-8","article-title":"Estradiol binding to cell surface raises cytosolic free calcium in T cells","volume":"422","author":"Benten","year":"1998","journal-title":"FEBS Lett"},{"issue":"2-3","key":"10.1016\/j.jaad.2019.08.001_bib36","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0378-4274(02)00203-5","article-title":"Estrogen receptor alpha in mouse splenic lymphocytes: possible involvement in immunity","volume":"133","author":"Sakazaki","year":"2002","journal-title":"Toxicol Lett"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.001_bib37","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12016-010-8203-5","article-title":"Estrogen receptors in immunity and autoimmunity","volume":"40","author":"Cunningham","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.jaad.2019.08.001_bib38","doi-asserted-by":"crossref","first-page":"e0172105","DOI":"10.1371\/journal.pone.0172105","article-title":"Neutrophils and neutrophil serine proteases are increased in the spleens of estrogen-treated C57BL\/6 mice and several strains of spontaneous lupus-prone mice","volume":"12","author":"Dai","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.001_bib39","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/cei.12394","article-title":"Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet's syndrome","volume":"178","author":"Marzano","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.jaad.2019.08.001_bib40","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1111\/bjd.15837","article-title":"Dysregulation of inflammatory gene expression in lesional and nonlesional skin of patients with pyoderma gangrenosum","volume":"178","author":"Ortega-Loayza","year":"2018","journal-title":"Br J Dermatol"},{"issue":"526","key":"10.1016\/j.jaad.2019.08.001_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aap9415","article-title":"Estrogen receptor \u03b1 contributes to T cell-mediated autoimmune inflammation by promoting T cell activation and proliferation","volume":"11","author":"Mohammad","year":"2018","journal-title":"Sci Signal"},{"issue":"29-30","key":"10.1016\/j.jaad.2019.08.001_bib42","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1016\/j.vaccine.2008.04.054","article-title":"Sexual dimorphism of humoral immunity with human vaccines","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219324946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962219324946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:54:41Z","timestamp":1759272881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962219324946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0190962219324946"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2019.08.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736395111.793568303","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence estimates for pyoderma gangrenosum in the United States: An age- and sex-adjusted population analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2019.08.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}